Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 1 | 1 | 3 | 16 | 16 | 16 |
| Reserves | 0 | 3 | 7 | 36 | 42 | 52 |
| Borrowings | 8 | 4 | 2 | 6 | 2 | 2 |
| Other Liabilities | 3 | 8 | 11 | 6 | 11 | 14 |
| Total Liabilities | 12 | 15 | 22 | 64 | 71 | 84 |
| AssetsFixed Assets | 5 | 4 | 8 | 7 | 6 | 11 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 0 |
| Investments | 0 | 0 | 0 | 0 | 1 | 1 |
| Other Assets | 8 | 11 | 14 | 57 | 63 | 71 |
| Total Assets | 12 | 15 | 22 | 64 | 71 | 84 |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (7.2×) and current (8.3×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 10% growth and a 7× exit, ₹150 only delivers your return if you pay ₹88. The price is currently baking in 21% growth.
EPS grows 10%/yr for 5 years, then fades to 6% over 2, exits at 7×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 10.0% | 19.87 |
| FY28 | 10.0% | 21.85 |
| FY29 | 10.0% | 24.04 |
| FY30 | 10.0% | 26.44 |
| FY31 | 10.0% | 29.09 |
| FY32 | 8.0% ·fade | 31.41 |
| FY33 | 6.0% ·fade | 33.30 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.